Emotional Distress Following Genetic Testing for Hereditary Breast and Ovarian Cancer: A Meta-Analytic Review

Health Psychology

Volumn 28, Issue 4, 2009, Pages 510-518

  Hamilton, Jada G ^a   Lobel, Marci ^a   Moyer, Anne ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

BRCA1 2 gene mutations; emotional distress; hereditary breast and ovarian cancer; meta analysis; predictive genetic testing

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ANXIETY; ARTICLE; BEHAVIOR; BREAST CANCER; CANCER DIAGNOSIS; COGNITION; EMOTIONAL STRESS; EMOTIONALITY; FAMILY HISTORY; GENE MUTATION; HETEROZYGOTE; HUMAN; MUTATIONAL ANALYSIS; OVARY CANCER; PERCEPTION; SYSTEMATIC REVIEW; UNITED STATES;

ADAPTATION, PSYCHOLOGICAL; ANXIETY; BRCA2 PROTEIN; BREAST NEOPLASMS; DEPRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMANS; OVARIAN NEOPLASMS; UBIQUITIN-PROTEIN LIGASES;

EID: 67650945260     PISSN: 02786133     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0014778     Document Type: Article

References (67)

1. American Cancer Society. Cancer facts & figures 2007 (2007), Author, Atlanta
2. Andrews L., Meiser B., Apicella C., and Tucker K. Psychological impact of genetic testing for breast cancer susceptibility in women of Ashkenazi Jewish background: A prospective study. Genetic Testing 8 (2004) 240-247
3. Baum A., Friedman A.L., and Zakowski S.G. Stress and genetic testing for disease risk. Health Psychology 16 (1997) 8-19
4. Bish A., Sutton S., Jacobs C., Levene S., Ramirez A., and Hodgson S. No news is (not necessarily) good news: Impact of preliminary results for BRCA1 mutation searches. Genetics in Medicine 4 (2002) 353-358
5. Bodurka-Bevers D., Basen-Engquist K., Carmack C.L., Fitzgerald M.A., Wolf J.K., de Moor C., et al. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecologic Oncology 78 (2000) 302-308
6. Borenstein M., Hedges L., Higgins J., and Rothstein H. Comprehensive meta-analysis Version 2.0 (2005), Biostat, Englewood, NJ
7. Butow P.N., Lobb E.A., Meiser B., Barratt A., and Tucker K.M. Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: A systematic review. Medical Journal of Australia 178 (2003) 77-81
8. Claes E., Evers-Kiebooms G., Boogaerts A., Decruyenaere M., Denayer L., and Legius E. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. American Journal of Medical Genetics Part A 116 (2003) 11-19
9. Claes E., Evers-Kiebooms G., Denayer L., Decruyenaere M., Boogaerts A., Philippe K., et al. Predictive genetic testing for hereditary breast and ovarian cancer: Psychological distress and illness representations 1 year following disclosure. Journal of Genetic Counseling 14 (2005) 349-363
10. Claus E.B., Schildkraut J.M., Thompson W.D., and Risch N.J. The genetic attributable risk of breast and ovarian cancer. Cancer 77 (1996) 2318-2324
11. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. (1988), Erlbaum, Hillsdale, NJ
12. Coyne J.C., Kruus L., Racioppo M., Calzone K.A., and Armstrong K. What do ratings of cancer-specific distress mean among women at high risk of breast and ovarian cancer?. American Journal of Medical Genetics Part A 116 (2003) 222-228
13. Croyle R.T., Achilles J.S., and Lerman C. Psychologic aspects of cancer genetic testing. A research update for clinicians. Cancer 80 (1997) 569-575
14. Croyle R.T., Smith K.R., Botkin J.R., and Baty B. Psychological responses to BRCA1 mutation testing: Preliminary findings. Health Psychology 16 (1997) 63-72
15. Derogatis L.R., Lipman R.S., Rickels K., Uhlenhuth E.H., and Covi L. The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory. Behavioral Science 19 (1974) 1-15
16. Derogatis L.R., and Melisaratos N. The Brief Symptom Inventory: An introductory report. Psychological Medicine 13 (1983) 595-605
17. Domchek S.M., and Weber B.L. Clinical management of BRCA1 and BRCA2 mutation carriers. Oncogene 25 (2006) 5825-5831
18. Dorval M., Gauthier G., Maunsell E., Dugas M.J., Rouleau I., Chiquette J., et al. No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result. Cancer Epidemiology Biomarkers & Prevention 14 (2005) 2862-2867
19. Dudok de Wit A.C., Duivenvoorden H.J., Passchier J., Niermeijer M.F., and Tibben A. Course of distress experienced by persons at risk for an autosomal dominant inheritable disorder participating in a predictive testing program: An explorative study. Psychosomatic Medicine 60 (1998) 543-549
20. Goldberg D.P., and Hillier V.F. A scaled version of the General Health Questionnaire. Psychological Medicine 9 (1979) 139-145
21. Gwyn K., Vernon S.W., and Conoley P.M. Intention to pursue genetic testing for breast cancer among women due for screening mammography. Cancer Epidemiology Biomarkers & Prevention 12 (2003) 96-102
22. Horowitz M.J., Wilner N., and Alvarez W. Impact of Event Scale: A measure of subjective stress. Psychosomatic Medicine 41 (1979) 209-218
23. Kinney A.Y., Bloor L.E., Mandal D., Simonsen S.E., Baty B.J., Holubkov R., et al. The impact of receiving genetic test results on general and cancer-specific psychologic distress among members of an African-American kindred with a BRCA1 mutation. Cancer 104 (2005) 2508-2516
24. Lerman C., and Croyle R.T. Psychological issues in genetic testing for breast-cancer susceptibility. Archives of Internal Medicine 154 (1994) 609-616
25. Lerman C., and Croyle R.T. Emotional and behavioral responses to genetic testing for susceptibility to cancer. Oncology 10 (1996) 191-195
26. Lerman C., Croyle R.T., Tercyak K.P., and Hamann H. Genetic testing: Psychological aspects and implications. Journal of Consulting and Clinical Psychology 70 (2002) 784-797
27. Lerman C., Narod S., Schulman K., Hughes C., Gomez-Caminero A., Bonney G., et al. BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision making and outcomes. JAMA 275 (1996, June 26) 1885-1892
28. Lerman C., and Schwartz M. Adherence and psychological adjustment among women at high risk for breast cancer. Breast Cancer Research and Treatment 28 (1993) 145-155
29. Lerman C., and Shields A.E. Genetic testing for cancer susceptibility: The promise and the pitfalls. Nature Reviews Cancer 4 (2004) 235-241
30. Lerman C., Trock B., Rimer B.K., and Jepson C. Psychological side effects of breast cancer screening. Health Psychology 10 (1991) 259-267
31. Liede A., Karlan B.Y., and Narod S.A. Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: A review of the literature. Journal of Clinical Oncology 22 (2004) 735-742
32. Lipsey M.W., and Wilson D.B. Practical meta-analysis (2001), Sage, Thousand Oaks, CA
33. Lloyd S., Watson M., Waites B., Meyer L., Eeles R., Ebbs S., et al. Familial breast cancer: A controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counselling. British Journal of Cancer 74 (1996) 482-487
34. Lobel M., Dias L., and Meyer B.A. Distress associated with prenatal screening for fetal abnormality. Journal of Behavioral Medicine 28 (2005) 65-76
35. Lodder L., Frets P.G., Trijsburg R.W., Meijers-Heijboer E.J., Klijn J.G.M., Duivenvoorden H.J., et al. Psychological impact of receiving a BRCA1/BRCA2 test result. American Journal of Medical Genetics 98 (2001) 15-24
36. Lodder L., Frets P.G., Trijsburg R.W., Tibben A., Meijers-Heijboer E.J., Duivenvoorden H.J., et al. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: An exploration of attitudes and psychological functioning during genetic testing. European Journal of Human Genetics 9 (2001) 492-500
37. Manne S., Audrain J., Schwartz M., Main D., Finch C., and Lerman C. Associations between relationship support and psychological reactions of participants and partners to BRCA1 and BRCA2 testing in a clinic-based sample. Annals of Behavioral Medicine 28 (2004) 211-225
38. Marteau T., and Richards M. The troubled helix: Social and psychological implications of the new human genetics (1996), Cambridge University Press, Cambridge, England
39. McNair D.M., Lorr M., and Droppleman L.F. Manual: Profile of Mood States (1971), EdITS, San Diego, CA
40. Meiser B., Butow P., Friedlander M., Barratt A., Schnieden V., Watson M., et al. Psychological impact of genetic testing in women from high-risk breast cancer families. European Journal of Cancer 38 (2002) 2025-2031
41. Meiser B., and Dunn S. Psychological impact of genetic testing for Huntington's disease: An update of the literature. Journal of Neurology, Neurosurgery and Psychiatry 69 (2000) 574-578
42. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P.A., Harshman K., Tavtigian S., et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266 (1994, October 7) 66-71
43. Moyer A., and Lobel M. The role of psychosocial research in understanding and improving the experience of breast cancer and breast cancer risk. In: Rawlinson M.C., and Lundeen S. (Eds). The voice of breast cancer in medicine and bioethics (philosophy and medicine) (2006), Springer, Dordrecht, the Netherlands 163-181
44. Myriad Genetic Laboratories. Know the facts so you can reduce your risk (2007), Myriad Genetics, Salt Lake City, UT
45. Nanda R., Schumm L.P., Cummings S., Fackenthal J.D., Sveen L., Ademuyiwa F., et al. Genetic testing in an ethnically diverse cohort of high-risk women: A comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 294 (2005, October 19) 1925-1933
46. Offit K. Clinical cancer genetics: Risk counseling & management (1998), Wiley-Liss, New York
47. O'Neill S.C., Demarco T., Peshkin B.N., Rogers S., Rispoli J., Brown K., et al. Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results. American Journal of Medical Genetics Part C-Seminars in Medical Genetics 142C (2006) 251-259
48. Ozakinci, G. (2004). Psychological and behavioral outcomes of genetic testing for BRCA1/2 mutations among Ashkenazi Jewish women. Unpublished doctoral dissertation, Rutgers, The State University of New Jersey, New Brunswick, NJ.
49. Pear R. Growth of genetic tests concerns federal panel. New York Times (2008, January 18). http://www.nytimes.com/2008/01/18/us/18tests.html Retrieved January 30, 2008, from http://www.nytimes.com/2008/01/18/us/18tests.html
50. Plon S.E., Peterson L.E., Friedman L.C., and Richards C.S. Mammography behavior after receiving a negative BRCA1 mutation test result in the Ashkenazim: A community-based study. Genetics in Medicine 2 (2000) 307-311
51. Reichelt J.G., Heimdal K., Moller P., and Dahl A.A. BRCA1 testing with definitive results: A prospective study of psychological distress in a large clinic-based sample. Familial Cancer 3 (2004) 21-28
52. Schlich-Bakker K.J., ten Kroode H.F.J., and Ausems M. A literature review of the psychological impact of genetic testing on breast cancer patients. Patient Education and Counseling 62 (2006) 13-20
53. Schmidt, F. L., Oh, I. -S., & Hayes, T. L. (in press). Fixed versus random effects models in meta-analysis: Model properties and an empirical comparison of differences in results. British Journal of Mathematical and Statistical Psychology
54. Schwartz M.D., Peshkin B.N., Hughes C., Main D., Isaacs C., and Lerman C. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. Journal of Clinical Oncology 20 (2002) 514-520
55. Smith, A. W. (2003). Physical activity as a moderator of distress during BRCA1/2 genetic testing. Unpublished doctoral dissertation, University of Pittsburgh, Pittsburgh, PA.
56. Spielberger C.D. Manual for the State-Trait Anxiety Inventory (1983), Consulting Psychologists Press, Palo Alto, CA
57. Spielberger C.D., Gorsuch R.L., Lushene R., Vagg P.R., and Jacobs G.A. State-Trait Anxiety Inventory for Adults. Sampler set: Manual, test, scoring key (1983), Mind Garden, Palo Alto, CA
58. Struewing J.P., Lerman C., Kase R.G., Giambarresi T.R., and Tucker M.A. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiology Biomarkers & Prevention 4 (1995) 169-173
59. Tercyak K.P., Lerman C., Peshkin B.N., Hughes C., Main D., Isaacs C., et al. Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk. Health Psychology 20 (2001) 217-222
60. U.S. Cancer Statistics Working Group. United States cancer statistics: 2003 incidence and mortality (2006), U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta
61. U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Recommendation statement. Annals of Internal Medicine 143 (2005) 355-361
62. van Dijk S., Timmermans D.R.M., Meijers-Heijboer H., Tibben A., van Asperen C.J., and Otten W. Clinical characteristics affect the impact of an uninformative DNA test result: The course of worry and distress experienced by women who apply for genetic testing for breast cancer. Journal of Clinical Oncology 24 (2006) 3672-3677
63. van Oostrom I., Meijers-Heijboer H., Duivenvoorden H.J., Brocker-Vriends A.H.J.T., van Asperen C.J., Sijmons R.H., et al. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress. Patient Education and Counseling 65 (2007) 58-68
64. van Roosmalen M.S., Stalmeier P.F.M., Verhoef L.C.G., Hoekstra-Weebers J., Oosterwijk J.C., Hoogerbrugge N., et al. Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer. American Journal of Medical Genetics Part A 124A (2004) 346-355
65. Watson M., Foster C., Eeles R., Eccles D., Ashley S., Davidson R., et al. Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. British Journal of Cancer 91 (2004) 1787-1794
66. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 378 (1995, February 22) 789-792
67. Zigmond A.S., and Snaith R.P. The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica 67 (1983) 361-370